Physician

Shailesh J Patel, MD

According to 2025 Medicare claims, Shailesh Patel, MD (NPI: 1407841521) practices hematology/oncology in the Pensacola-Ferry Pass-Brent, FL market, with the plurality of this provider's patient population coming from Escambia, FL. This provider's primary affiliated billing organization is WOODLANDS MEDICAL SPECIALISTS P A (NPI: 1225274772; TIN: 261802830) and primary practice location at 32503-2339. Patel is affiliated with the Aledade 154 FL GA MSSP Enhanced (ACO ID: A5357), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,091 traditional Medicare patients, billed 250,300 HCPCS/CPT codes, and received $3,005,649 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,202 prescription claims across 227 beneficiaries totaling $5,056,546 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 14 claims. Open Payments data shows 16 records totaling $351. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,185,214 to $5,056,546. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2015 Medicare payment: $3,694,607 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,756,426 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,041,147 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,536,556 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,492,161 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,715,157 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,181,878 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,492,465 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,162,468 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,005,649 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155,660215,341$3,694,607
20166,171254,869$3,756,426
20172,575224,779$3,041,147
20181,074252,416$3,536,556
20191,064254,657$3,492,161
20201,004242,295$3,715,157
20211,018264,100$4,181,878
2022901244,609$3,492,465
2023916228,141$3,162,468
20241,091250,300$3,005,649

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.6M$5.2M2015 Drug cost: $2,185,214 (USD; Tot_Drug_Cst)2016 Drug cost: $2,574,176 (USD; Tot_Drug_Cst)2017 Drug cost: $2,514,649 (USD; Tot_Drug_Cst)2018 Drug cost: $2,904,977 (USD; Tot_Drug_Cst)2019 Drug cost: $3,086,437 (USD; Tot_Drug_Cst)2020 Drug cost: $4,196,487 (USD; Tot_Drug_Cst)2021 Drug cost: $4,665,116 (USD; Tot_Drug_Cst)2022 Drug cost: $5,188,060 (USD; Tot_Drug_Cst)2023 Drug cost: $3,853,658 (USD; Tot_Drug_Cst)2024 Drug cost: $5,056,546 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152452,022$2,185,214
20162451,909$2,574,176
20172291,744$2,514,649
20182221,552$2,904,977
20192331,330$3,086,437
20202211,420$4,196,487
20212291,378$4,665,116
20222201,428$5,188,060
20232161,218$3,853,658
20242271,202$5,056,546

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.6K$9.3K2015 Medicare payment: $4,961 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $2,476 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $194 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $9,252 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $5,146 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $5,244 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $6,906 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R71$4,961
2016N/R37$2,476
2017N/R26$194
2018N/R41$9,252
2019N/R32$5,146
2020N/R43$5,244
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R14$6,906
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more131131$113
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6181,515$92
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's496880$13
96375Injection of additional new drug or substance into vein167613$11
96372Injection of drug or substance under skin or into muscle138404$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CalquenceAcalabrutinib Maleate792,550$1,232,195
LenalidomideLenalidomide481,337$569,728
PomalystPomalidomide18504$437,825
RevlimidLenalidomide28735$430,868
BrukinsaZanubrutinib25750$293,953

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$351Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shailesh J. Patel, MD?

Tedicare shows public-source Medicare data for Shailesh J. Patel, MD (NPI 1407841521), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shailesh J. Patel, MD have ACO affiliation data?

Shailesh J. Patel, MD is shown with ACO affiliation data for Aledade 154 FL GA MSSP Enhanced (MSSP, ACO ID A5357).

What billing organization is linked to Shailesh J. Patel, MD?

Shailesh J. Patel, MD is linked to WOODLANDS MEDICAL SPECIALISTS P A (billing NPI 1225274772) in the available physician profile data.

Does Shailesh J. Patel, MD have Open Payments data?

Shailesh J. Patel, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.